Cargando…
Identification of Novel Dopamine D(2) Receptor Ligands—A Combined In Silico/In Vitro Approach
Diseases of the central nervous system are an alarming global problem showing an increasing prevalence. Dopamine receptor D(2) (D(2)R) has been shown to be involved in central nervous system diseases. While different D(2)R-targeting drugs have been approved by the FDA, they all suffer from major dra...
Autores principales: | Zell, Lukas, Lainer, Constanze, Kollár, Jakub, Temml, Veronika, Schuster, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318694/ https://www.ncbi.nlm.nih.gov/pubmed/35889317 http://dx.doi.org/10.3390/molecules27144435 |
Ejemplares similares
-
Dopamine Receptor Ligand Selectivity—An In Silico/In Vitro Insight
por: Zell, Lukas, et al.
Publicado: (2023) -
Identification
of Novel β-Tubulin Inhibitors
Using a Combined In Silico/In Vitro Approach
por: Horgan, Mark James, et al.
Publicado: (2023) -
Combination of In Silico and In Vitro Screening to Identify
Novel Glutamate Carboxypeptidase
II Inhibitors
por: Temml, Veronika, et al.
Publicado: (2023) -
Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods
por: Hsieh, Chia-Ju, et al.
Publicado: (2021) -
Discovery
of New Liver X Receptor Agonists by Pharmacophore
Modeling and Shape-Based Virtual Screening
por: Temml, Veronika, et al.
Publicado: (2014)